Stanford University genetics professor Dr. Stanley Cohen paid $29.2 million to settle a lawsuit over misleading claims he made about Nuredis Inc., his now-dissolved biotechnology company.

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he ...

Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the ...

Stanford University are preparing for a Phase II in Pulmonary Arterial Hypertension (PAH)Kiel, Germany, January 8, 2025 – tiakis ...

Tran Le was an engineering student at Stanford University when she tried to enroll in a clinical trial for her chronic ...

In a new study led by Stanford University scientists, researchers engineered a common skin bacteria to express a tetanus toxin on their surfaces. When mice were colonized by these bacteria ...

Researchers at Oregon Health and Science University and Stanford University have found that there is a protein common in the majority of cells that transports genetic material from a cell's outer ...

Biotechnology has enormous potential to ... and Abeliuk were working at Stanford University, spending a lot of time on tasks that they thought could be automated. “We saw an opportunity to ...

The broad field of biotechnology and applied microbiology covers topics on the manipulation of living organisms to make products or solve problems to meet human needs. Students in this field study ...

Helmy is an entrepreneur and pioneer in the biotech industry. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology ...